Precision hypofractionated radiation therapy in poor performing patients with non-small cell lung cancer: Phase 1 dose escalation trial

International Journal of Radiation Oncology Biology Physics

Volumn 93, Issue 1, 2015, Pages 72-81

  Westover, Kenneth D ^a   Loo, Billy W ^b   Gerber, David E ^a   Iyengar, Puneeth ^a   Choy, Hak ^a   Diehn, Maximilian ^b   Hughes, Randy ^a   Schiller, Joan ^a   Dowell, Jonathan ^a   Wardak, Zabi ^a   Sher, David ^c   Christie, Alana ^d   Xie, Xian Jin ^d   Corona, Irma ^a   Sharma, Akanksha ^a   Wadsworth, Margaret E ^e   Timmerman, Robert ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e Radiation Oncology of Mississippi   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CHEMORADIOTHERAPY; COST EFFECTIVENESS; DISEASE CONTROL; DISEASES; DRUG PRODUCTS; ONCOLOGY; RADIATION;

CONCURRENT CHEMORADIATION; CONFORMAL RADIATION THERAPY; EASTERN COOPERATIVE ONCOLOGY GROUP; LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCERS; LUNG CANCER THERAPY; METHODS AND MATERIALS; NON SMALL CELL LUNG CANCER; TECHNOLOGICAL ADVANCEMENT;

RADIOTHERAPY;

ADULT; ADVANCED CANCER; ADVERSE OUTCOME; ANEMIA; ANOREXIA; ARTICLE; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DYSPHAGIA; DYSPNEA; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PAIN; PRECISION HYPOFRACTIONATED RADIATION THERAPY; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE ESCALATION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOTHERAPY PLANNING SYSTEM; ADENOCARCINOMA; AGED; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PROCEDURES; SEVERITY OF ILLNESS INDEX;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SEVERITY OF ILLNESS INDEX;

EID: 84939422319     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.05.004     Document Type: Article

References (26)

1. A. Auperin, C. Le Pechoux, E. Rolland, and et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
2. R. Komaki, C. Scott, D. Ettinger, and et al. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04 Int J Radiat Oncol Biol Phys 38 1997 149 155
3. K. Furuse, M. Fukuoka, M. Kawahara, and et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
4. R.O. Dillman, S.L. Seagren, K.J. Propert, and et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 1990 940 945
5. W.J. Curran Jr., R. Paulus, C.J. Langer, and et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410 J Natl Cancer Inst 103 2011 1452 1460
6. G. Clamon, J. Herndon, R. Cooper, and et al. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: A phase III trial of the cancer and leukemia group B and the Eastern Cooperative Oncology Group J Clin Oncol 17 1999 4 11
7. R.K. Kumar, A. Saxena, and K.K. Talwar Lone atrial fibrillation with complete heart block in a child Int J Cardiol 30 1991 349 351
8. R. Timmerman, R. McGarry, C. Yiannoutsos, and et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
9. R. Timmerman, R. Paulus, J. Galvin, and et al. Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
10. D. Palma, O. Visser, F.J. Lagerwaard, and et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-trend analysis J Clin Oncol 28 2010 5153 5159
11. Y. Nagata, K. Takayama, Y. Matsuo, and et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431
12. P. Baumann, J. Nyman, M. Hoyer, and et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
13. A. Amini, S.H. Lin, C. Wei, and et al. Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer Radiat Oncol 7 2012 33
14. L.N. Nguyen, R. Komaki, P. Allen, and et al. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: A retrospective review Int J Radiat Oncol Biol Phys 44 1999 1053 1056
15. J.D. Bradley, R. Paulus, R. Komaki, and et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): A randomised, two-by-two factorial phase 3 study Lancet Oncol 16 2015 187 199
16. L. Cohen Biophysical Models in Radiation Oncology 1983 CRC Press Boca Raton, FL
17. A. Trotti, A.D. Colevas, A. Setser, and et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
18. D.R. Gomez, M. Gillin, Z. Liao, and et al. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer Int J Radiat Oncol Biol Phys 86 2013 665 670
19. L. Kepka, D. Tyc-Szczepaniak, and K. Bujko Dose-per-fraction escalation of accelerated hypofractionated three-dimensional conformal radiotherapy in locally advanced non-small cell lung cancer J Thorac Oncol 4 2009 853 861
20. J.B. Adkison, D. Khuntia, S.M. Bentzen, and et al. Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase I dose escalation study Technol Cancer Res Treat 7 2008 441 447
21. D.M. Cannon, M.P. Mehta, J.B. Adkison, and et al. Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer J Clin Oncol 31 2013 4343 4348
22. M.F. Osti, L. Agolli, M. Valeriani, and et al. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer Int J Radiat Oncol Biol Phys 85 2013 e157 e163
23. S. Firat, R.W. Byhardt, E. Gore, and et al. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: An institutional analysis of patients treated on four RTOG studies Int J Radiat Oncol Biol Phys 54 2002 357 364
24. J.D. Cox Large-dose fractionation (hypofractionation) Cancer 55 1985 2105 2111
25. S. Aneja, and J.B. Yu Comparative effectiveness research in radiation oncology: Stereotactic radiosurgery, hypofractionation, and brachytherapy Semin Radiat Oncol 24 2014 35 42
26. K. Lang, M.D. Marciniak, D. Faries, and et al. Costs of first-line doublet chemotherapy and lifetime medical care in advanced non-small-cell lung cancer in the United States Value Health 12 2009 481 488